10-Q Filing

TANKE BIOSCIENCES CORP CIK: 1452011 Q3 2013

Filing Information

Form Type	10-Q
Accession Number	`0001213900-13-006510`
Period End Date	20130930
Filing Date	20131114
Fiscal Year	2013
Fiscal Period	Q3
XBRL Instance	tnbi-20130930.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 79 Income Statement 85 Cash Flow Statement 70

Balance Sheet 79 line items

Line Item	Tag	Value	Unit	Period
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	50.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	50.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$10.03M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	13.32M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$6.17M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	13.32M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$5.05M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$7.70M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$11.04M	USD	Point-in-time
Restricted cash	`RestrictedCashAndCashEquivalentsAtCarryingValue`	$231.84K	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	13.32M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	13.32M	shares	Point-in-time
Accounts receivable, net	`AccountsReceivableNetCurrent`	$2.76M	USD	Point-in-time
Accounts receivable, net	`AccountsReceivableNetCurrent`	$1.99M	USD	Point-in-time
Inventories, net	`InventoryNet`	$1.41M	USD	Point-in-time
Inventories, net	`InventoryNet`	$1.65M	USD	Point-in-time
Loans to customer and supplier	`AccountsAndOtherReceivablesNetCurrent`	$2.89M	USD	Point-in-time
Loans to customer and supplier	`AccountsAndOtherReceivablesNetCurrent`	$2.96M	USD	Point-in-time
Other receivables	`OtherReceivables`	$483.88K	USD	Point-in-time
Other receivables	`OtherReceivables`	$738.73K	USD	Point-in-time
Prepayments	`AdvancesToSuppliers`	$6.47M	USD	Point-in-time
Prepayments	`AdvancesToSuppliers`	$9.03M	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$132.75K	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$30.05K	USD	Point-in-time
Deferred tax assets	`DeferredTaxAssetsNetCurrent`	$27.77K	USD	Point-in-time
Deferred tax assets	`DeferredTaxAssetsNetCurrent`	$27.04K	USD	Point-in-time
Total current assets	`AssetsCurrent`	$19.70M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$22.37M	USD	Point-in-time
Property, plant and equipment, net	`PropertyPlantAndEquipmentNet`	$6.34M	USD	Point-in-time
Property, plant and equipment, net	`PropertyPlantAndEquipmentNet`	$4.81M	USD	Point-in-time
Construction in progress	`ConstructionInProgressGross`	$295.25K	USD	Point-in-time
Construction in progress	`ConstructionInProgressGross`	$1.63M	USD	Point-in-time
Intangible asset, net	`FiniteLivedIntangibleAssetsNet`	$1.15M	USD	Point-in-time
Intangible asset, net	`FiniteLivedIntangibleAssetsNet`	$1.24M	USD	Point-in-time
Other non-current assets	`OtherAssetsNoncurrent`	$134.74K	USD	Point-in-time
Total assets	`Assets`	$28.85M	USD	Point-in-time
Total assets	`Assets`	$28.81M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$646.65K	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$640.78K	USD	Point-in-time
Advance from customers	`AdvancesFromCustomers`	$128.32K	USD	Point-in-time
Advance from customers	`AdvancesFromCustomers`	$99.41K	USD	Point-in-time
Other payables and accrued liabilities	`AccountsPayableAndOtherAccruedLiabilitiesCurrent`	$901.80K	USD	Point-in-time
Other payables and accrued liabilities	`AccountsPayableAndOtherAccruedLiabilitiesCurrent`	$942.79K	USD	Point-in-time
Income tax payable	`AccruedIncomeTaxesCurrent`	$1.94M	USD	Point-in-time
Income tax payable	`AccruedIncomeTaxesCurrent`	$1.84M	USD	Point-in-time
Convertible notes, net	`ConvertibleDebtCurrent`	$7.51M	USD	Point-in-time
Convertible notes, net	`ConvertibleDebtCurrent`	$7.27M	USD	Point-in-time
Current portion of long-term borrowings	`LongTermDebtCurrent`	$1.14M	USD	Point-in-time
Current portion of long-term borrowings	`LongTermDebtCurrent`	$1.27M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$12.24M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$12.10M	USD	Point-in-time
Advance from government grant	`GovernmentGrantsForResearchAndDevelopmentProjectsOutstanding`	$37.95K	USD	Point-in-time
Advance from government grant	`GovernmentGrantsForResearchAndDevelopmentProjectsOutstanding`	$129.99K	USD	Point-in-time
Long-term borrowings	`LongTermDebtNoncurrent`	$792.57K	USD	Point-in-time
Long-term borrowings	`LongTermDebtNoncurrent`	$732.65K	USD	Point-in-time
Total liabilities	`Liabilities`	$12.93M	USD	Point-in-time
Total liabilities	`Liabilities`	$13.10M	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Common stock, $0.001 par value, 50,000,000 shares authorized, 13,324,083 issued and outstanding as of September 30, 2013 and December 31, 2012	`CommonStockValue`	$13.32K	USD	Point-in-time
Common stock, $0.001 par value, 50,000,000 shares authorized, 13,324,083 issued and outstanding as of September 30, 2013 and December 31, 2012	`CommonStockValue`	$13.32K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$12.22M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$12.22M	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$2.49M	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$1.63M	USD	Point-in-time
Statutory reserve	`StatutoryAccountingPracticesRetainedEarningsNotAvailableForDividends`	$373.41K	USD	Point-in-time
Statutory reserve	`StatutoryAccountingPracticesRetainedEarningsNotAvailableForDividends`	$373.41K	USD	Point-in-time
Accumulated other comprehensive income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$1.32M	USD	Point-in-time
Accumulated other comprehensive income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$658.87K	USD	Point-in-time
Total Tanke Biosciences Corporation stockholders' equity	`StockholdersEquity`	$15.75M	USD	Point-in-time
Total Tanke Biosciences Corporation stockholders' equity	`StockholdersEquity`	$15.56M	USD	Point-in-time
Non-controlling interest	`MinorityInterest`	$155.59K	USD	Point-in-time
Non-controlling interest	`MinorityInterest`	$171.44K	USD	Point-in-time
Total Equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$15.92M	USD	Point-in-time
Total Equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$15.71M	USD	Point-in-time
Total Liabilities and Equity	`LiabilitiesAndStockholdersEquity`	$28.85M	USD	Point-in-time
Total Liabilities and Equity	`LiabilitiesAndStockholdersEquity`	$28.81M	USD	Point-in-time

Income Statement 85 line items

Line Item	Tag	Value	Unit	Period
Net sales	`SalesRevenueNet`	$21.88M	USD	3 Qtrs
Net sales	`SalesRevenueNet`	$6.04M	USD	1 Quarter
Net sales	`SalesRevenueNet`	$16.28M	USD	3 Qtrs
Net sales	`SalesRevenueNet`	$9.91M	USD	1 Quarter
Costs of sales	`CostOfGoodsSold`	$11.10M	USD	3 Qtrs
Costs of sales	`CostOfGoodsSold`	$4.35M	USD	1 Quarter
Costs of sales	`CostOfGoodsSold`	$6.52M	USD	1 Quarter
Costs of sales	`CostOfGoodsSold`	$14.17M	USD	3 Qtrs
Gross profit	`GrossProfit`	$1.69M	USD	1 Quarter
Gross profit	`GrossProfit`	$7.71M	USD	3 Qtrs
Gross profit	`GrossProfit`	$5.18M	USD	3 Qtrs
Gross profit	`GrossProfit`	$3.39M	USD	1 Quarter
Selling expenses	`SellingExpense`	$1.71M	USD	3 Qtrs
Selling expenses	`SellingExpense`	$2.08M	USD	3 Qtrs
Selling expenses	`SellingExpense`	$611.88K	USD	1 Quarter
Selling expenses	`SellingExpense`	$796.30K	USD	1 Quarter
Administrative expenses	`GeneralAndAdministrativeExpense`	$1.80M	USD	3 Qtrs
Administrative expenses	`GeneralAndAdministrativeExpense`	$574.09K	USD	1 Quarter
Administrative expenses	`GeneralAndAdministrativeExpense`	$1.36M	USD	1 Quarter
Administrative expenses	`GeneralAndAdministrativeExpense`	$3.34M	USD	3 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$67.34K	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortization`	$43.07K	USD	3 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$183.89K	USD	3 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$16.64K	USD	1 Quarter
(Loss) income from operations	`OperatingIncomeLoss`	$-420.54K	USD	3 Qtrs
(Loss) income from operations	`OperatingIncomeLoss`	$-530.34K	USD	1 Quarter
(Loss) income from operations	`OperatingIncomeLoss`	$4.17M	USD	3 Qtrs
(Loss) income from operations	`OperatingIncomeLoss`	$2.18M	USD	1 Quarter
Other (expense) income	`OtherNonoperatingIncomeExpense`	$40.21K	USD	3 Qtrs
Other (expense) income	`OtherNonoperatingIncomeExpense`	$-3.12K	USD	1 Quarter
Interest income	`InvestmentIncomeInterest`	$147.04K	USD	1 Quarter
Interest income	`InvestmentIncomeInterest`	$23.57K	USD	1 Quarter
Interest income	`InvestmentIncomeInterest`	$193.03K	USD	3 Qtrs
Interest income	`InvestmentIncomeInterest`	$173.18K	USD	3 Qtrs
Interest credit (expense)	`InterestExpense`	$1.06M	USD	3 Qtrs
Interest credit (expense)	`InterestExpense`	$316.42K	USD	1 Quarter
Interest credit (expense)	`InterestExpense`	$207.86K	USD	3 Qtrs
Interest credit (expense)	`InterestExpense`	$-46.58K	USD	1 Quarter
Amortization of discount on notes	`AmortizationOfFinancingCosts`	$402.39K	USD	3 Qtrs
Amortization of discount on notes	`AmortizationOfFinancingCosts`	$2.08M	USD	3 Qtrs
Amortization of discount on notes	`AmortizationOfFinancingCosts`	$698.50K	USD	1 Quarter
(Loss) income before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$1.19M	USD	1 Quarter
(Loss) income before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-339.85K	USD	1 Quarter
(Loss) income before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$1.22M	USD	3 Qtrs
(Loss) income before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-817.40K	USD	3 Qtrs
Income tax benefit (expense)	`IncomeTaxExpenseBenefit`	$58.70K	USD	3 Qtrs
Income tax benefit (expense)	`IncomeTaxExpenseBenefit`	$222.51K	USD	1 Quarter
Income tax benefit (expense)	`IncomeTaxExpenseBenefit`	$-26.91K	USD	1 Quarter
Income tax benefit (expense)	`IncomeTaxExpenseBenefit`	$652.71K	USD	3 Qtrs
Net (loss) income	`ProfitLoss`	$-312.94K	USD	1 Quarter
Net (loss) income	`ProfitLoss`	$570.07K	USD	3 Qtrs
Net (loss) income	`ProfitLoss`	$-876.11K	USD	3 Qtrs
Net (loss) income	`ProfitLoss`	$968.63K	USD	1 Quarter
Net loss attributable to non-controlling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$-10.86K	USD	1 Quarter
Net loss attributable to non-controlling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$-15.86K	USD	3 Qtrs
Net (loss) income attributable to Tanke Biosciences Corporation	`NetIncomeLoss`	$968.63K	USD	1 Quarter
Net (loss) income attributable to Tanke Biosciences Corporation	`NetIncomeLoss`	$570.07K	USD	3 Qtrs
Net (loss) income attributable to Tanke Biosciences Corporation	`NetIncomeLoss`	$-302.08K	USD	1 Quarter
Net (loss) income attributable to Tanke Biosciences Corporation	`NetIncomeLoss`	$-860.25K	USD	3 Qtrs
Net (loss) income	`ProfitLoss`	$-312.94K	USD	1 Quarter
Net (loss) income	`ProfitLoss`	$570.07K	USD	3 Qtrs
Net (loss) income	`ProfitLoss`	$-876.11K	USD	3 Qtrs
Net (loss) income	`ProfitLoss`	$968.63K	USD	1 Quarter
Foreign currency translation adjustments	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent`	$664.82K	USD	3 Qtrs
Foreign currency translation adjustments	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent`	$152.23K	USD	1 Quarter
Foreign currency translation adjustments	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent`	$109.07K	USD	3 Qtrs
Foreign currency translation adjustments	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent`	$-101.88K	USD	1 Quarter
Comprehensive (loss) income	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$-160.72K	USD	1 Quarter
Comprehensive (loss) income	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$679.14K	USD	3 Qtrs
Comprehensive (loss) income	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$866.75K	USD	1 Quarter
Comprehensive (loss) income	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$-211.29K	USD	3 Qtrs
Comprehensive loss attributable to non-controlling interest	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$-3.46K	USD	3 Qtrs
Comprehensive loss attributable to non-controlling interest	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$-1.94K	USD	1 Quarter
Comprehensive (loss) income attributable to Tanke Biosciences Corporation	`ComprehensiveIncomeNetOfTax`	$-207.83K	USD	3 Qtrs
Comprehensive (loss) income attributable to Tanke Biosciences Corporation	`ComprehensiveIncomeNetOfTax`	$679.14K	USD	3 Qtrs
Comprehensive (loss) income attributable to Tanke Biosciences Corporation	`ComprehensiveIncomeNetOfTax`	$866.75K	USD	1 Quarter
Comprehensive (loss) income attributable to Tanke Biosciences Corporation	`ComprehensiveIncomeNetOfTax`	$-158.77K	USD	1 Quarter
Basic and diluted	`EarningsPerShareBasicAndDiluted`	$0.07	USD	1 Quarter
Basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.07	USD	3 Qtrs
Basic and diluted	`EarningsPerShareBasicAndDiluted`	$0.04	USD	3 Qtrs
Basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.02	USD	1 Quarter
Basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	13.32M	shares	3 Qtrs
Basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	13.32M	shares	3 Qtrs
Basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	13.32M	shares	1 Quarter
Basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	13.32M	shares	1 Quarter

Cash Flow Statement 70 line items

Line Item	Tag	Value	Unit	Period
Net (loss) income	`ProfitLoss`	$-312.94K	USD	1 Quarter
Net (loss) income	`ProfitLoss`	$570.07K	USD	3 Qtrs
Net (loss) income	`ProfitLoss`	$-876.11K	USD	3 Qtrs
Net (loss) income	`ProfitLoss`	$968.63K	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$404.12K	USD	3 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$629.40K	USD	3 Qtrs
Amortization of discount on convertible notes payable	`AmortizationOfFinancingCosts`	$402.39K	USD	3 Qtrs
Amortization of discount on convertible notes payable	`AmortizationOfFinancingCosts`	$2.08M	USD	3 Qtrs
Amortization of discount on convertible notes payable	`AmortizationOfFinancingCosts`	$698.50K	USD	1 Quarter
Amortization of capitalized offering costs	`OtherAmortizationOfDeferredCharges`	$115.69K	USD	3 Qtrs
Amortization of capitalized offering costs	`OtherAmortizationOfDeferredCharges`	$598.09K	USD	3 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$357.89K	USD	3 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$567.91K	USD	3 Qtrs
Inventories	`IncreaseDecreaseInInventories`	$450.06K	USD	3 Qtrs
Inventories	`IncreaseDecreaseInInventories`	$235.77K	USD	3 Qtrs
Note receivables and payables - related parties	`IncreaseDecreaseInDueFromRelatedParties`	$-239.48K	USD	3 Qtrs
Other receivables	`IncreaseDecreaseInOtherReceivables`	$143.93K	USD	3 Qtrs
Other receivables	`IncreaseDecreaseInOtherReceivables`	$184.76K	USD	3 Qtrs
Deferred tax asset	`IncreaseDecreaseInDeferredIncomeTaxes`	$733.00	USD	3 Qtrs
Deferred tax asset	`IncreaseDecreaseInDeferredIncomeTaxes`	$285.00	USD	3 Qtrs
Prepayments	`IncreaseDecreaseInPrepaidExpense`	$-1.85M	USD	3 Qtrs
Prepayments	`IncreaseDecreaseInPrepaidExpense`	$-388.39K	USD	3 Qtrs
Other current assets	`IncreaseDecreaseInOtherCurrentAssets`	$12.99K	USD	3 Qtrs
Other current assets	`IncreaseDecreaseInOtherCurrentAssets`	$23.05K	USD	3 Qtrs
Other non-current assets	`IncreaseDecreaseInOtherNoncurrentAssets`	$-206.57K	USD	3 Qtrs
Other non-current assets	`IncreaseDecreaseInOtherNoncurrentAssets`	$-134.74K	USD	3 Qtrs
Advance from government grant	`IncreaseDecreaseInDeferredRevenue`	$-168.56K	USD	3 Qtrs
Advance from government grant	`IncreaseDecreaseInDeferredRevenue`	$92.04K	USD	3 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-5.87K	USD	3 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-202.83K	USD	3 Qtrs
Other payables and accrued liabilities	`IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities`	$-41.00K	USD	3 Qtrs
Other payables and accrued liabilities	`IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities`	$159.03K	USD	3 Qtrs
Income tax payable	`IncreaseDecreaseInAccruedIncomeTaxesPayable`	$529.39K	USD	3 Qtrs
Income tax payable	`IncreaseDecreaseInAccruedIncomeTaxesPayable`	$102.08K	USD	3 Qtrs
Advance from customer	`IncreaseDecreaseInCustomerAdvances`	$-28.91K	USD	3 Qtrs
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$3.83M	USD	3 Qtrs
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$1.38M	USD	3 Qtrs
Increase in loans to customer and supplier	`IncreaseDecreaseInAccountsAndOtherReceivables`	$363.32K	USD	3 Qtrs
Purchase of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$2.43M	USD	3 Qtrs
Purchase of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$799.92K	USD	3 Qtrs
Purchase of intangible assets	`PaymentsToAcquireIntangibleAssets`	$39.89K	USD	3 Qtrs
Purchase of intangible assets	`PaymentsToAcquireIntangibleAssets`	$477.66K	USD	3 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-2.47M	USD	3 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-1.64M	USD	3 Qtrs
Change in restricted cash	`IncreaseDecreaseInRestrictedCashAndInvestmentsForOperatingActivities`	$-168.16K	USD	3 Qtrs
Change in restricted cash	`IncreaseDecreaseInRestrictedCashAndInvestmentsForOperatingActivities`	$-231.84K	USD	3 Qtrs
Payment on convertible notes	`RepaymentsOfConvertibleDebt`	$160.84K	USD	3 Qtrs
Proceeds from long-term borrowings	`ProceedsFromIssuanceOfLongTermDebt`	$964.80K	USD	3 Qtrs
Proceeds from long-term borrowings	`ProceedsFromIssuanceOfLongTermDebt`	$878.12K	USD	3 Qtrs
Principal payments for long-term borrowings	`RepaymentsOfLongTermDebt`	$1.21M	USD	3 Qtrs
Net cash (used in) provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-170.20K	USD	3 Qtrs
Net cash (used in) provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$1.05M	USD	3 Qtrs
Effect of exchange rate fluctuations on cash and cash equivalents	`EffectOfExchangeRateOnCashAndCashEquivalents`	$109.07K	USD	3 Qtrs
Effect of exchange rate fluctuations on cash and cash equivalents	`EffectOfExchangeRateOnCashAndCashEquivalents`	$152.26K	USD	3 Qtrs
Net (decrease) increase in cash	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$3.34M	USD	3 Qtrs
Net (decrease) increase in cash	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-1.12M	USD	3 Qtrs
Cash and cash equivalents, beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$10.03M	USD	Point-in-time
Cash and cash equivalents, beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$6.17M	USD	Point-in-time
Cash and cash equivalents, beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$5.05M	USD	Point-in-time
Cash and cash equivalents, beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$7.70M	USD	Point-in-time
Cash and cash equivalents, beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$11.04M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashAndCashEquivalentsAtCarryingValue`	$10.03M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashAndCashEquivalentsAtCarryingValue`	$6.17M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashAndCashEquivalentsAtCarryingValue`	$5.05M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashAndCashEquivalentsAtCarryingValue`	$7.70M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashAndCashEquivalentsAtCarryingValue`	$11.04M	USD	Point-in-time
Cash paid for interest	`InterestPaid`	$162.54K	USD	3 Qtrs
Cash paid for interest	`InterestPaid`	$306.80K	USD	3 Qtrs
Cash paid for income taxes	`IncomeTaxesPaidNet`	$7.15K	USD	3 Qtrs
Cash paid for income taxes	`IncomeTaxesPaidNet`	$278.23K	USD	3 Qtrs

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.